Artificial intelligence, machine learning-based automated fibrosis quantification in preclinical models of pulmonary fibrosis

Precise, quantitative assessment of disease features on histological images from preclinical models is essential for therapeutic development in diseases such as pulmonary fibrosis. However, current histological fibrosis scoring methods, such as Ashcroft Scoring have several limitations, including high time and labor requirements by expert pathologist readers, subjective semi-quantitative assessment and interobserver variability. The goal of this study was to assess the feasibility of a supervised AI/ML-based framework for automated, rapid, objective quantification of fibrosis content and spatial distribution in histology slides obtained from a variety of preclinical fibrosis models. Lung histology slides stained with Masson’s trichrome were obtained from 194 individual mice from two independent cohorts of preclinical mouse models of pulmonary fibrosis. A supervised AI/ML algorithm was trained, validated and independently tested to automatically detect, segment and quantify fibrosis compared against independent Ashcroft scoring by an expert pathologist reader. Spatial distribution of AI/ML-segmented fibrosis patterns were compared across histology images. AI/ML-based fibrosis quantification demonstrated strong correlation with Ashcroft score, both in the validation cohort (Spearman ρ = 0.85, CI: 0.72–0.92), and in the independent, de novo test cohort (Spearman ρ = 0.89, CI: 0.84–0.93) with rapid assessment time (~ 1.5 times faster). Additionally, Ripley’s K analysis revealed differences in spatial distribution of AI-segmented fibrosis patterns among samples with similar Ashcroft scores and overall fibrosis content. The AI/ML framework developed and independently validated in this study provides a robust, computationally-efficient method for precise, user-friendly, objective measurement of fibrosis content and spatial distribution, which would have major utility in preclinical therapeutic trials and investigations of disease pathogenesis.

Authors

Institutions

Publication Details

Journal
Respiratory Research
Published
2026-02-04
DOI
https://doi.org/10.1186/s12931-026-03536-2
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial intelligence, machine learning-based automated fibrosis quantification in preclinical models of pulmonary fibrosis

Scott Turner, Sreyankar Nandy, Ashley E. Bass, Rachel S. Knipe et al.
Respiratory Research
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Artificial intelligence, machine learning-based automated fibrosis quantification in preclinical models of pulmonary fibrosis

Scott Turner, Sreyankar Nandy, Ashley E. Bass, Rachel S. Knipe, S.R. Berigei, Markus D. Herrmann, Benjamin W. Roop, Nery Matias Calmo, Daniela A. R. Santos, Lida P. Hariri, Gail Lee, Amalia DeCoursey
article en

Abstract

Precise, quantitative assessment of disease features on histological images from preclinical models is essential for therapeutic development in diseases such as pulmonary fibrosis. However, current histological fibrosis scoring methods, such as Ashcroft Scoring have several limitations, including high time and labor requirements by expert pathologist readers, subjective semi-quantitative assessment and interobserver variability. The goal of this study was to assess the feasibility of a supervised AI/ML-based framework for automated, rapid, objective quantification of fibrosis content and spatial distribution in histology slides obtained from a variety of preclinical fibrosis models. Lung histology slides stained with Masson’s trichrome were obtained from 194 individual mice from two independent cohorts of preclinical mouse models of pulmonary fibrosis. A supervised AI/ML algorithm was trained, validated and independently tested to automatically detect, segment and quantify fibrosis compared against independent Ashcroft scoring by an expert pathologist reader. Spatial distribution of AI/ML-segmented fibrosis patterns were compared across histology images. AI/ML-based fibrosis quantification demonstrated strong correlation with Ashcroft score, both in the validation cohort (Spearman ρ = 0.85, CI: 0.72–0.92), and in the independent, de novo test cohort (Spearman ρ = 0.89, CI: 0.84–0.93) with rapid assessment time (~ 1.5 times faster). Additionally, Ripley’s K analysis revealed differences in spatial distribution of AI-segmented fibrosis patterns among samples with similar Ashcroft scores and overall fibrosis content. The AI/ML framework developed and independently validated in this study provides a robust, computationally-efficient method for precise, user-friendly, objective measurement of fibrosis content and spatial distribution, which would have major utility in preclinical therapeutic trials and investigations of disease pathogenesis.

Respiratory ResearchVol. 27(1)
Tufts University (US), Harvard University (US), Massachusetts General Hospital (US), Pliant (United States) (US)
Decent work and economic growth
Openalex Percentile: Top 68%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.